SARC018_SPORE02: Phase II Study of Mocetinostat Administered With Gemcitabine for Patients With Metastatic Leiomyosarcoma With Progression or Relapse Following Prior Treatment With Gemcitabine-Containing Therapy

Sarcoma - United States
doi 10.1155/2018/2068517

Related search